CN101824406B - 重组β-内酰胺酶与RGD融合蛋白及其在医学中的应用 - Google Patents
重组β-内酰胺酶与RGD融合蛋白及其在医学中的应用 Download PDFInfo
- Publication number
- CN101824406B CN101824406B CN2009100680381A CN200910068038A CN101824406B CN 101824406 B CN101824406 B CN 101824406B CN 2009100680381 A CN2009100680381 A CN 2009100680381A CN 200910068038 A CN200910068038 A CN 200910068038A CN 101824406 B CN101824406 B CN 101824406B
- Authority
- CN
- China
- Prior art keywords
- rgd
- gly
- lactamase
- fusion rotein
- ala
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100680381A CN101824406B (zh) | 2009-03-06 | 2009-03-06 | 重组β-内酰胺酶与RGD融合蛋白及其在医学中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100680381A CN101824406B (zh) | 2009-03-06 | 2009-03-06 | 重组β-内酰胺酶与RGD融合蛋白及其在医学中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101824406A CN101824406A (zh) | 2010-09-08 |
CN101824406B true CN101824406B (zh) | 2012-05-30 |
Family
ID=42688571
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100680381A Expired - Fee Related CN101824406B (zh) | 2009-03-06 | 2009-03-06 | 重组β-内酰胺酶与RGD融合蛋白及其在医学中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101824406B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012044939A2 (en) * | 2010-09-30 | 2012-04-05 | Emil Golub | Method of preparing a dry powder from a water bacteria extract-concentrate |
CN112574316A (zh) * | 2015-07-02 | 2021-03-30 | 博际生物医药科技(杭州)有限公司 | 用于肿瘤靶向治疗的白细胞介素-15融合蛋白 |
US10947270B2 (en) * | 2015-08-27 | 2021-03-16 | National Yang-Ming University | Targeted prodrug cytosine deaminase fusion carrier and application thereof |
CN112300289B (zh) * | 2019-12-30 | 2022-06-10 | 中国药科大学 | RGD4C融合抗TNFα纳米抗体蛋白、制备方法及其应用 |
-
2009
- 2009-03-06 CN CN2009100680381A patent/CN101824406B/zh not_active Expired - Fee Related
Non-Patent Citations (4)
Title |
---|
Fiona A et al.A β-lactamase with reduced immunogenicity for the targeted delivery of chemotherapeutics using antibody-directed enzyme prodrug therapy.《Mol Cancer ther》.2005,第4卷(第11期),摘要部分. * |
I.Niculescu-Duvaz et al.Antibody-directed enzyme prodrug therapy :a review.《Advanced Drug Delivery Reviews》.1997,(第26期),全文. * |
Kenneth et al.Antibody-directed enzyme prodrug therapy for cancer.《Peptides,protein & Antisense》.2004,第4卷(第11期),全文. * |
肖斌等.靶向性抗肿瘤融合蛋白RGD-hIL-24的构建、表达和体外活性研究.《中华微生物和免疫学杂志》.2006,第26卷(第12期),第1059-1061页. * |
Also Published As
Publication number | Publication date |
---|---|
CN101824406A (zh) | 2010-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102101888B (zh) | 一种新型抗eb病毒所致肿瘤多肽及其应用与制备方法 | |
CN101143894A (zh) | 高效抑制血管生成多肽及其物理化学修饰方法和应用 | |
CN101824406B (zh) | 重组β-内酰胺酶与RGD融合蛋白及其在医学中的应用 | |
US10875903B2 (en) | Bifunctional fusion proteins to inhibit angiogenesis in tumor microenvironment and to activate adaptive immune responses and the genes and uses thereof | |
JPH06507639A (ja) | セレクチンとb百日咳毒素の間のアミノ酸シーケンスの相同性−それから誘導されるペプチド、それに対する抗体、薬剤組成物 | |
JP2016514111A (ja) | アルブミン結合アルギニンデイミナーゼ融合たんぱく質を含有する医薬組成物 | |
CN101717449B (zh) | 重组TRAIL-Fc融合蛋白及其制备和应用 | |
CN102227443A (zh) | 治疗性核糖核酸酶 | |
CN108503698A (zh) | 鲍曼不动杆菌Ata蛋白的免疫原性 | |
CN103897038A (zh) | 一种肿瘤抑制多肽及用途 | |
CN102286074B (zh) | 一种cd13靶向肽ngr及其应用 | |
CN101497666B (zh) | 一种双特异性寡肽-力达霉素强化融合蛋白Ec-LDP-Hr-AE | |
CN111995686B (zh) | 一种具有抗血管生成活性的药物及其制备方法 | |
CN101671396A (zh) | 与胶原蛋白特异结合的血管内皮生长因子及其应用 | |
CN107236046A (zh) | 一种重组人内皮抑素融合蛋白及其制备方法和应用 | |
CN107236025A (zh) | 与cd56分子特异性结合的多肽及其应用 | |
CN106699850A (zh) | Rbbp4靶向多肽和抗肿瘤多肽及其应用 | |
CN101182355A (zh) | 抗菌肽融合蛋白基因、其重组载体、其转化体及其表达产物 | |
CN106729769B (zh) | Tem1特异性荧光探针及其应用 | |
CN105504063A (zh) | 一类防御素-白蛋白的抗肿瘤融合蛋白及其制备和应用 | |
CN109400711A (zh) | 一种PDGFRβ靶向性肿瘤坏死因子相关凋亡诱导配体变异体及其制备方法和用途 | |
Reitinger et al. | High-yield recombinant expression of the extremophile enzyme, bee hyaluronidase in Pichia pastoris | |
CN108949730A (zh) | 一种重组变构胶原酶的制备方法及其应用 | |
CN101781369A (zh) | 一种重组人精氨酸酶融合蛋白及其应用 | |
KR100612673B1 (ko) | 세포도입성 보톡신 융합단백질 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: TIANJIN TIANYI KEYUAN TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: RADIOLOGY RESEARCH INSTITUTE,CHINESE ACADEMY OF MEDICAL SCIENCES Effective date: 20150508 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150508 Address after: 300192, D floor, No. 238 Bai Causeway Road, Tianjin Patentee after: Tianjin Tianyi Keyuan Technology Co. Ltd. Address before: 300192, 238 Bai Causeway Road, Tianjin, Nankai District Patentee before: Radiology Research Institute ,Chinese Academy of Medical Sciences |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120530 Termination date: 20170306 |